Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis

Liver International

Volumn 28, Issue 8, 2008, Pages 1080-1086

  Mishra, Poonam ^a   Nugent, Clarke ^a   Afendy, Arian ^a   Bai, Chunhong ^a   Bhatia, Priya ^a   Afendy, Mariam ^a   Fang, Yun ^a   Elariny, Hazem ^a   Goodman, Zachary ^b   Younossi, Zobair M ^a  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Apnoea; NASH; Sleep

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APNEA ATTACK; APNEA HYPOPNEA INDEX; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BARIATRIC SURGERY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NOCTURNAL OXYGEN SATURATION; NONALCOHOLIC FATTY LIVER; OXYGEN SATURATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREOPERATIVE EVALUATION; RESPIRATORY DISTURBANCE INDEX; RISK FACTOR; SLEEP APNEA SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BARIATRIC SURGERY; CASE-CONTROL STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FATTY LIVER; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY, MORBID; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 48949106838     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01822.x     Document Type: Article

References (37)

1. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
2. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004; 2: 262-5.
3. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
4. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003; 32: 869-94.
5. Arias MA, Alonso-Fernandez A, Garcio-Rio F, Pagola C. Association between obesity and obstructive sleep apnea. Eur Heart J 2005; 26: 2744-5.
6. Coughlin SR, Mawdsley L, Mugarza JA, Calverly PMA, Wilding JPH. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.
7. Ip MSM, Lam B, Ng MMT, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6.
8. Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82.
9. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep- disordered breathing, glucose intolerance, and insulin resistance the sleep heart health study. Am J Epidemiol 2004; 160: 521-30.
10. Saibara T, Nozaki Y, Nemoto Y, Ono M, Onishi S. NSH and Pickwickian syndrome. Lancet 2002; 359: 980.
11. Weiss JW, Launois SH, Anand A, Garpestad E. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis 1999; 41: 367-76.
12. Leung RST, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001; 164: 2147-65.
13. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-6.
14. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
15. Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005; 50: 2338-43.
16. Tatsura O, Masahiro N, Yutaka N, Susumu I. Evaluation of episodes of sleep apnea in patients with liver cirrhosis. J Med Investig 2006; 53: 77-88.
17. Crespo J, Cifrian J, Pinto JA, Jimenez-Gomez A, Pons-Romero F. Sleep apnea obstructive syndrome: A new complication previously underscribed in cirrhotic patients with ascites. Am J Gastroenterol 2003; 98: 2815-6.
18. Edmison J, McCullough AJ. Pathogenesis of non-alcoholic steatohepatitis: human data. Clin Liver Dis 2007; 1: 75-104.
19. Mishra P, Weinstein M, Vithiananthan S, et al. Mean nocturnal oxygen saturation but not apnea-hypopnea index (AHI) predicts non-alcoholic fatty liver disease (NAFLD) activity score (NAS) in a cohort of patients with morbid obesity undergoing bariatric surgery. Hepatology 2006; 44 (Suppl. 1): 654A, Abstract 1247.
20. Rechtschaffen A, Kales AA, eds. A Manual of Standardized Terminology, Techniques and Scoring for Sleep Stages of Human Subjects. Washington, DC: Government Printing Office, 1968 (NIH Publication No: 204).
21. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
22. Tanne F, Gagnadoux F, Chazouiller O, et al. Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41: 1290-6.
23. Savransky V, Nanayakkara A, Vivero A, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007; 45: 1007-13.
24. Caraceni P, Ryu HSM, Subbotin V, et al. Rat hepatocytes isolated from alcohol-induced fatty liver have an increased sensitivity to anoxic injury. Hepatology 1997; 25: 943-9.
25. Tatsumi K, Saibara T. Effects of obstructive sleep apnea syndrome on hepatic steatosis and nonalcoholic steatohepatitis. Hepatol Res 2005; 30: 100-4.
26. Pessayre D, Mansouri A, Hauzi D, et al. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-73.
27. Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: Sites and mechanisms. Diabetologia 2005; 48: 634-42.
28. Pessayre D, Mansouri A, Hauzi D, et al. Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999; 15: 367-73.
29. Chitturi S, Farell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27-41.
30. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000; 343: 1467-76.
31. krueger JM, Majde JA Cytokines and sleep. Int Arch Allergy Immunol 1995; 106: 97-100.
32. Uthgenannt D, Schoolmann D, Pietrowsky R, Fehm HL, Born J. Effects of sleep on the production of cytokines in humans. Psychosomat Med 1995; 57: 97-104.
33. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnea: The importance of visceral obesity and insulin resistance. J Intern Med 2003; 254: 32-4.
34. Warne JP. Tumour necrosis factor alpha: A key regulator of adipose tissue mass. J Endocrinol 2003; 177: 351-5.
35. Satapathy SK, Garg S, Chauhan R, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1946-52.
36. Adams LA, Zien CO, Angulo P, et al. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 2365-8.
37. Chin K, Nakamura T, Takahashi K, et al. Effects of obstructive sleep apnea syndrome on serum aminotranseferase levels in obese patients. Am J Med 2003; 114: 370-6.